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Abstract
Autoimmune uveitis is an intraocular inflammation that arises through autoreactive T-cells attacking the inner eye,
eventually leading to blindness. However, the contributing molecular pathomechanisms within the affected tissues remain
as yet elusive. The extracellular matrix (ECM) is a highly dynamic structure that varies tremendously and influences the
encompassing tissue. In order to assess ECM re-modeling in autoimmune uveitis, we investigated the expression of ECM
molecules fibronectin and osteopontin in vitreous and retina samples. This was carried out in the only spontaneous animal
model for human autoimmue uveitis, namely equine recurrent uveitis (ERU) that resembles the human disease in clinical as
well as in immunopathological aspects. ERU is a naturally occurring autoimmune disease in horses that develops frequently
and has already proved its value to study disease-related pathomechanisms. Western blot analysis of fibronectin and
osteopontin in healthy and uveitic vitreous revealed significant reduction of both proteins in uveitis. Immunohistochemical
expression of fibronectin in healthy retinas was restricted to the inner limiting membrane abutting vimentin positive Mu ¨ller
cell endfeet, while in uveitic sections, a disintegration of the ILM was observed changing the fibronectin expression to a
dispersed pattern extending toward the vitreous. Retinal expression of osteopontin in control tissue was found in a
characteristic Mu ¨ller cell pattern illustrated by co-localization with vimentin. In uveitic retinas, the immunoreactivity of
osteopontin in gliotic Mu ¨ller cells was almost absent. The ability of Mu ¨ller cells to express fibronectin and osteopontin was
additionally shown by immunocytochemistry of primary cultured equine Mu ¨ller cells and the equine Mu ¨ller cell line eqMC-7.
In conclusion, severe ECM re-modeling in autoimmune uveitis reported here, might affect the adhesive function of
fibronectin and thus the anchoring of Mu ¨ller cell endfeet to the ILM. Furthermore, the absence of osteopontin in gliotic
Mu ¨ller cells might represent reduced neuroprotection, an osteopontin attribute that is intensively discussed.
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Introduction
Autoimmune uveitis is a sight-threatening intraocular inflam-
mation driven by eye-invading autoreactive T-cells that cross the
blood-retinal barrier [1,2]. However, the majority of molecular
pathomechanisms within the eye contributing to the onset of
disease and to the loss of immune-privilege remain as yet
unresolved [3]. In order to understand the pathogenesis and the
underlying molecular processes of autoimmune uveitis, different
experimental animal models are investigated [4]. Among these,
equine recurrent uveitis (ERU) is the only spontaneous animal
model for autoimmune uveitis, and ERU resembles closely the
human disease in many clinical as well as immunopathological
aspects [5,6]. In contrast to the human disease, however, ERU is a
frequent pathology in the equine population. Both, the high
incidence as well as the close similarity to the human condition,
render ERU an ideal tool for studying autoimmune uveitis-related
pathomechanisms [7]. The course of the disease is characterized
by recurring relapses ultimately leading to tissue destruction
and loss of vision [7,8]. Autoaggressive T-cells that cross the
blood-retinal barrier and attack the inner eye are specific for
several retinal autoantigens [8,9]. Among them, cellular retinalde-
hyde binding protein (CRALBP) was first discovered in ERU [9]
and proved subsequently to be a frequently targeted autoantigen
in human autoimmune uveitis [10]. The multilayered retina that
provides the basis for vision represents the target tissue of
autoimmune uveitis [10,11]. Retinal neuronal cells are heavily
influenced by the surrounding extracellular matrix [12]. Since
ECM is a highly dynamic structure, the properties can vary
tremendously from one physiological state to another [13].
Additionally, ECM molecules of chronically inflamed tissues can
be altered by cytokines and proteases that are produced by
infiltrating immune cells [14]. ECM does not only fill intercellular
space, proteins of the ECM are also involved in a variety of major
functions including cellular signalling, regulation of development
and differentiation and mediation of cell-matrix adhesion among
others [15,16,17].
Fibronectin, a glycoprotein of the ECM, mediates cellular-ECM
interactions and comprises functions such as cell adhesion,
migration, growth and differentiation [18]. It was reported that
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Mu ¨ller cells [19]. In autoimmune uveitis, Mu ¨ller cells convert into
a gliotic state and change their morphology and function
profoundly [20]. Since we found an upregulation of fibronectin
in autoimmune uveits in a previous proteomic study comparing
the retinal membrane proteome of healthy to uveitic retinas [3],
we chose this ECM protein for more detailed investigations.
Osteopontin, a major phosphoprotein of the ECM, has gained
interest since reports of its functions associated with inflammation
and neuronal disorders are inconsistent. Neuroprotective effects
versus proinflammatory properties of osteopontin are discussed.
The neuroprotective potential of osteopontin was demonstrated in
several studies. Osteopontin treatment of oxygen and glucose
deprived cortical neuron cultures protected against cell death and
intracerebral ventricular application of osteopontin reduced
infarct size in a murine stroke model [21]. Recently, we published
a study that confirmed a neuroprotective effect of osteopontin. We
showed that osteopontin is derived from retinal Mu ¨ller cells and
has a positive survival effect on cultured primary porcine
photoreceptors. Furthermore, we demonstrated a reduced apo-
ptotic rate of photoreceptors in cultured retina explants from a
mouse harbouring a mutation resulting in retinal degeneration
under the influence of osteopontin [22]. However, proinflamma-
tory features of osteopontin were also shown. Induction of
experimental autoimmune uveitis (EAU) in mice with human
interphotoreceptor retinoid-binding protein was accompanied
with an elevated level of plasma osteopontin, while induction of
EAU in osteopontin deficient mice showed milder clinical and
histopathological symptoms assuming that osteopontin is proin-
flammatory [23]. This could be confirmed by downregulation of
osteopontin with small interfering RNA in mice with induced
EAU [24].
The purpose of this study was to investigate the expression of
ECM proteins fibronectin and osteopontin in a spontaneous
animal model for autoimmune uveitis to gain further information
about these proteins and the role of ECM in a retinal disorder.
Materials and Methods
Sample collection and preparation
For this study, a total of 17 ERU diseased specimens and 16
healthy controls were collected and processed. ERU eye tissue
specimens derived from horses that were treated in the equine
clinic and diagnosed with ERU according to clinical criteria as
described [6].
Control samples (retinas, vitreous and posterior eyecups) were
obtained from horses euthanized due to incurable and ERU
unrelated diseases or where obtained from a local slaughterhouse.
Vitreous samples of ERU cases were obtained during therapeutic
pars-plana vitrectomy. Uveitic eyes derived from horses that had
to be enucleated during a therapeutical procedure. The collection
and use of equine eyes derived from horses that were killed due to
a research-unrelated cause, was approved for purposes of scientific
research by the appropriate board of the veterinary inspection
office Munich, Germany (Permit Number: 8.175.10024.1319.3).
Horses were treated according to the ethical principals and
guidelines for scientific experiments on animals according to the
ARVO statement for the use of animals in Ophthalmic and Vision
research. No experimental animals were involved in this study.
Vitreous samples were stabilized with EDTA-free protease
inhibitor (Roche, Mannheim, Germany), then lyophilized, there-
after solubilised in ultrapure water and dialysed against 50 mM
phosphate buffer (pH 7.6). Protein content was determined using
the Bradford assay (Sigma-Aldrich, Deisenhofen, Germany).
For immunohistochemistry, posterior eyecups were immersion-
fixed with Bouin’s solution (Sigma-Aldrich, Deisenhofen, Ger-
many), dehydrated in a series of alcohols and sliced into pre-
assigned fragments as described before [25]. Resulting tissue
blocks were embedded in paraffin, sectioned (8 mm) and mounted
on coated slides (Superforst, Thermo Scientific, Bonn, Germany).
SDS-PAGE and Western Blotting of vitreous samples
Equal total protein amounts from vitreous samples were
separated by SDS-PAGE (8% and 12% gels) and blotted semidry
onto polyvinyl difluoride (PVDF) membranes (GE Healthcare,
Freiburg, Germany). Unspecific binding was blocked with 1%
polyvinylpyrrolidon - tween (PVP-T) for 1 hour at room
temperature. Blots were incubated with primary antibodies (anti-
osteopontin and anti-fibronectin) at 4uC overnight and then
washed 3 times in phosphate buffered saline – tween (PBS-T;
136.9 mM NaCl, 8.1 mM Na2HPO462H2O, 1.4 mM KH2PO4,
2.6 mM KCl, pH 7.2, 0.05% Tween20). Binding was detected by
horseradish peroxidise (HRP)-coupled secondary antibody incu-
bation for 1 hour at room temperature. After 6 further washing
steps in PBS-T, signals were detected by enhanced chemolumi-
nescence on X-ray films (Fuji; Christiansen, Planegg, Germany).
Films were scanned on a transmission scanner and quantification
of western blot signals by densitometry was performed using
ImageQuantTL software (GE Healthcare). Osteopontin and
fibronectin abundances between ERU cases and controls were
statistically analyzed using the Mann-Whitney test. The differences
in protein expression were considered significant if the significance
level was #0.05.
Immunohistochemistry on retina sections
Heat antigen retrieval was performed at 99uC for 15 min in
0.1 M EDTA-NaOH (pH 8.0). To prevent unspecific antibody
binding, sections were blocked with 1% BSA in tris buffered saline
– tween (TBS-T; 10 mM Tris, 150 mM NaCl, pH 7.2, 0.1%
Tween20) containing additionally 5% of a non-immune serum
derived from the secondary antibody animal species, for 40 min at
RT prior to every primary antibody incubation.
Multiple labelling was performed consecutively, with blocking
steps (ProteinBlock; Dako, Hamburg, Germany) between single
antibody incubations. For triple labelling, sections were first
consecutively incubated with primary antibodies (osteopontin and
fibronectin at 4uC, both overnight; Vimentin for 3 hours at RT).
Each primary antibody incubation was followed by the respective
secondary antibody (30 min at RT). Cell nuclei were counter-
stained with 49,6-diamidino-2-phenylindole (DAPI; Invitrogen,
Karlsruhe, Germany; 1:1000). Finally, the sections were mounted
with glass coverslips using Dako fluorescence mounting medium
(Dako, Hamburg, Germany). Fluorescent images were recorded
with an Axio Imager M1 or Z1 and the Axio Vision 4.6 software
(both from Zeiss, Go ¨ttingen, Germany) at a total magnification of
406.
Negative controls for all immunohistochemical experiments
included omission of the primary antibody as well as incubation
with isotype-matched primary antibody of irrelevant specificity.
Isolation of equine Mu ¨ller cells
Primary Mu ¨ller cells were isolated from healthy equine retinas
according to a method described previously [26]. Briefly, vitreous
and pigment epithelial attachments were carefully removed from
retinas and subsequent disintegration was accomplished mechan-
ically. Retinal dissociation was achieved by treatment with
activated papain (Worthington Biochemical Corporation, Trois-
dorf, Germany) for 30 min at 37uC; reaction was stopped by
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Berlin, Germany) containing 10% fetal calf serum (FCS;
Biochrom, Berlin, Germany). Desoxyribonuklease (Sigma-Aldrich,
Deisenhofen, Germany) was added and resuspended cells were
seeded in culture flasks (Cell
+; Sarstedt, Nu ¨mbrecht, Germany)
after trituration and centrifugation. The cells were allowed to
attach for 24 h at 37uC and 5% CO2 in an incubator and non-
attached cells were removed. Using the above described method,
we previously established the first equine Mu ¨ller cell line that was
named eqMC-7 (equine Mu ¨ller cell line – 7) [26]. All
immunocytochemical experiments were performed on primary
cultured equine Mu ¨ller cells and eqMC-7 cells.
Immunocytochemistry of equine Mu ¨ller cells
For immunocytochemistry eqMC-7 cells and primary cultured
equine Mu ¨ller cells were trypsinized and seeded onto glass slides
which were placed in culture plates. Cells were cultured in DMEM
omitting FCS supplement for 16 h and were allowed to attach to
the glass surface within this time. Slides were rinsed in phosphate
buffered saline (PBS) and fixed in acetone for 10 min. To prevent
unspecific antibody binding, slides were blocked with 1% BSA in
TBS-T containing 5% appropriate serum (according to the species
the secondary antibody was produced in) for 40 min at room
temperature prior to every primary antibody incubation. Fluores-
cence labelling and image acquisition was performed similarly as
for immunohistochemistry of retina sections.
Antibodies
Goat polyclonal antibody against mouse osteopontin from R&D
Systems (Wiesbaden-Nordenstadt, Germany) was used at a
dilution of 1:100 for immunohisto- and immunocytochemical
experiments and at a dilution of 1:500 for western blots. Polyclonal
rabbit-anti-fibronectin antibody (Thermo Fisher Scientific, Bonn,
Germay) was applied at a dilution of 1:100 in immunohistochem-
istry and 1:400 in immunocytochemistry. It was used at 1:1000 in
western blotting experiments. Monoclonal mouse anti-vimentin
antibody (Clone V9) from Sigma-Aldrich (Deisenhofen, Germany)
was used at a dilution of 1:400 in immunohisto- and immunocy-
tochemistry. Alexa Fluor labelled secondary IgG antibodies were
obtained from Invitrogen (Karlsruhe, Germany) and all used at a
working dilution of 1:500. We used goat anti-mouse IgG coupled
to alexa 488, goat anti-rabbit IgG alexa 647 and donkey anti-goat
IgG alexa 546.
Results
Osteopontin and fibronectin expression is significantly
decreased in uveitic vitreous
In order to investigate the occurrence and expression level of
fibronectin and osteopontin in vitreous of healthy and ERU
diseased eyes, we performed SDS-PAGE and subsequent western
blotting experiments. Expression of fibronectin in healthy
(Figure 1A, gray box) and diseased vitreous samples (Fig. 1A,
white box) was detected at a molecular weight of approximately
260 kDa. Determination and comparison of signal intensities
revealed significantly (*p#0.05) reduced expression levels of
fibronectin in vitreous of uveitic eyes (median 74%) compared to
control vitreous specimens (median 99.8%). Osteopontin positive
reaction was detected in healthy as well as in diseased vitreous
samples in form of a double band at the molecular weight of
30 kDa (Fig. 1B) and a band triplet at the molecular weight of
72 kDa (Fig. 1C). Intensities of both signals were determined and
compared between healthy (Fig. 1B and C, gray boxes) and uveitic
specimens (Fig. 1B and C, white boxes). Signal intensity of the
double band at 30 kDa was significantly (*p#0.05) decreased in
vitreous from ERU diseased eyes (median 2.8%) compared to
healthy control vitreous (median 99.5%) (Fig. 1B). Quantification
of the Osteopontin signal at 72 kDa also revealed a significant
reduction in uveitic vitreous (median 14.3%) in comparison to
control samples (median 98%) (Fig. 1C).
Fibronectin immunoreactivity is detectable at the ILM
and upregulated in uveitic retinas
In a previous proteomics study comparing the retinal mem-
brane fraction of healthy and uveitic samples we already
demonstrated that retinal fibronectin expression is increased in
autoimmune uveitis compared to control [3]. To further
characterize this extracellular matrix protein we were interested
in the expression pattern of fibronectin in the healthy equine retina
and whether the retinal distribution would change in autoimmune
uveitis. To this end we performed immunohistochemical fluores-
cent stainings of healthy (Fig. 2, left panels) and uveitic (Fig. 2,
Figure 1. Fibronectin and osteopontin expression in control and uveitic vitreous. Western blot signals for fibronectin (A) and for
osteopontin at 30 kDa (B) and at 72 kDa (C) of control (grey boxes, representative band above) and uveitic vitreous samples (white boxes,
representative band above) were quantified by densitometry and statistical significance was calculated using the Mann-Whitney test. Data are
represented in a box plot and median is marked by a black line in boxes. Expression level of fibronectin (A) was significantly (*p=0.02) reduced in
diseased (n=4) compared to healthy vitreous (n=5) with a difference in the median values of 25.8%. Quantification of osteopontin expression at
30 kDa (B) resulted in a significant (*p=0.02) decrease in uveitic vitreous (n=4) compared to control samples (n=5) with the median values of 99.5%
(healthy) and 2.8% (diseased). Osteopontin at 72 kDa (C) shows a significantly (*p=0.02) decreased expression level in uveitic vitreous (n=4)
compared to controls (n=5). Median value of healthy vitreous was 98% in contrast to 14.3% of uveitic samples.
doi:10.1371/journal.pone.0027674.g001
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PLoS ONE | www.plosone.org 3 December 2011 | Volume 6 | Issue 12 | e27674Figure 2. Expression pattern of fibronectin and osteopontin in healthy and uveitic retinal tissue. Retinal expression of fibronectin
(magenta), osteopontin (red) and vimentin (green) in a representative healthy (left panels) and ERU diseased retina (right panels). Differential
interference contrast (DIC) image of a representative control retina (A) and uveitic retina section (B), display tissue destruction and a loss of
photoreceptor outer segments in the ERU case. Fibronectin is expressed along the ILM in healthy retina as a continuous band (C) but shows a spotted
pattern along the disintegrated ILM and in the outer uveitic retina (D). Osteopontin expression in healthy retina shows a Mu ¨ller cell like pattern and a
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(DIC) image of control equine retinas (Fig. 2A) compared to
uveitic retinas (Fig. 2B) showed destruction of the multilayered
retina, especially a loss of photoreceptor outer segments in uveitic
eyes (Fig. 2B). In healthy equine retinas, fibronectin immunore-
activity was detected solely in a smooth thin band along the inner
limiting membrane (ILM) (Fig. 2C). Staining against fibronectin in
uveitic retinas showed a disintegration of the ILM that resulted in
fibronectin expression in a broad band extending towards the
vitreous (Fig. 2D). Additionally, fibronectin expression was
observed at the level of the outer limiting membrane as well as
in isolated dotted structures throughout the tissue (Fig. 2D).
Osteopontin is expressed along retinal Mu ¨ller cells and
downregulated in uveitic retinas
Osteopontin was shown to be expressed in retinal ganglion cells
within the mouse retina and this expression pattern, as well as the
intensity, persisted in mice with interphotoreceptor retinoid-
binding protein (IRBP) induced experimental autoimmune uveitis
(EAU) [27]. However, in a recently published study we
demonstrated that the secreted glycoprotein osteopontin was
expressed in retinal Mu ¨ller cells of mouse retinal explants [22].
Therefore we were interested in further characterizing osteopontin
expression within the normal equine retina and investigate the
potential changes during autoimmune uveitis. Immunolabelling of
osteopontin in healthy retinas revealed osteopontin expression in a
Mu ¨ller cell characteristic pattern including staining at the ILM.
Additionally, osteopontin expression was observed in the area
where photoreceptor outer segments and microvilli of the retinal
pigment epithel (RPE) intertwine (Fig. 2E). Within uveitic equine
retinas however, the expression of osteopontin almost disappeared
(Fig. 2F) compared to control sections (Fig. 2E). A distinct positive
immunoreactivity was only detected at the outer limiting
membrane where photoreceptor outer segments mostly perished
(Fig. 2F).
Fibronectin closely neighbours Mu ¨ller cell endfeet at the
ILM and osteopontin co-localizes with vimentin in the
equine retina
In order to further characterize the expression patterns of
fibronectin and osteopontin within the equine retina, we
performed triple labellings of healthy and uveitis diseased retina
sections with the Mu ¨ller cell marker vimentin. In healthy retinas,
vimentin was characteristically expressed throughout the entire
Mu ¨ller cell from endfeet that cover the ILM to branches that pass
through the inner (INL) and outer nuclear layer (ONL) to
terminate at the outer limiting membrane (OLM) (Fig. 2G). In
uveitic retina sections (Fig. 2H), a characteristic vimentin
upregulation indicates Mu ¨ller cell gliosis as it occurs in
autoimmune uveitis [3,20]. This is associated with loss of the
characteristic morphology and a partial detachment of the Mu ¨ller
cell endfeet from the ILM (Fig. 2H). Triple labelling of healthy
retina sections (Fig. 2I) revealed a closely neighbouring expression
of fibronectin and vimentin at the ILM that abuts Mu ¨ller cell
endfeet. Futhermore, a co-localisation of osteopontin and vimentin
was seen especially at the Mu ¨ller cell endfeet. In uveitic retinas
(Fig. 2J) the gliotic Mu ¨ller cells apparently lost osteopontin
expression. The spotted fibronectin expression at the disintegrated
ILM does not show close association to the partly disbanded
Mu ¨ller cell endfeet membranes anymore (Fig. 2J).
Primary equine Mu ¨ller cells and eqMC-7 cells express
osteopontin and fibronectin
In order to verify the Mu ¨ller cell associated osteopontin
immunoreactivity observed in the retina (Fig. 2), and to evaluate
the fibronectin expression at the ILM (Fig. 2), we performed
immunocytochemical stainings of primary cultured equine Mu ¨ller
cellsandthepreviouslyestablished equineMu ¨llercellline-7(eqMC-
7) [26]. Cells were grown on glass slides and immunolabelled for
fibronectin, osteopontin and the Mu ¨ller cell marker vimentin.
Cultured equine Mu ¨ller cells showed a postitive immunoreactivity
with the fibronectin-specific antibody (Fig. 3A). The expression was
displayed in a spotted pattern that appeared predominantly at the
nucleus and the surrounding area (Fig. 3A). Cultured equine Mu ¨ller
cells stained positive for osteopontin in a distribution similar to that
of vimentin (Fig. 3B). Cultured Mu ¨ller cells showed strong
immunoreactivity for the intermediate filament vimentin in an
elongated, thread-like expression pattern that appeared throughout
the entire cell and is characteristic for Mu ¨ller cells (Fig. 3C) [26].
Overlay image (Fig. 3D) revealed the co-localization of fibronectin
and osteopontin within the equine Mu ¨ller cell. Similar expression
patterns of vimentin, osteopontin and fibronectin were found for
eqMC-7 cells (data not shown).
Discussion
A comprehensive understanding of autoimmune uveitis patho-
genesis remains as yet elusive [6]. Analysis of differentially expressed
proteins in target tissues of healthy and diseased condition provides
a basis for analysis of pathogenesis-associated processes [28,29]. To
this end,proteomicstudies and subsequent evaluationhave revealed
several enlisted proteins, biomarkers and pathways in autoimmune
uveitis contributing to a better understanding of disease develop-
ment and progression [28,29,30,31]. In a specific comparative
proteomic analysis of retinal membrane protein enriched fractions,
fibronectin, a protein of the ECM, was found to be upregulated in
ERU [3]. In order to evaluate this finding and further characterize
its role in uveitis pathogenesis, we investigated the expression of
fibronectin in vitreous and retina of control and uveitic samples
since the vitreous body and the retina have been shown to play a
crucial role in the pathogenesis of autoimmune uveitis [3,28,29]. In
the present study we demonstrated a significant downregulation of
fibronectin in vitreous samples of ERU diseased horses compared to
controls by western blotting experiments (Fig. 1A). Furthermore, we
showed a positive immunoreactivity for fibronectin exclusively at
the ILM of healthy equine retinas (Fig. 2C). This expression varied
in uveitic retinas displaying a disintegrated pattern along the ILM
expanding towards the vitreous (Fig. 2D). With these results we
could again confirm that comparative proteomic analysis is a
reliable tool to reveal expression changes of molecules and can
provide a basis to suggest pathways potentially involved in disease
positive staining of photoreceptor outer segments (E). This expression almost disappears in ERU diseased retina (F). Mu ¨ller cells of control section
show a distinct immunoreactivity for vimentin throughout the retina (G) while uveitic retina displays characteristic gliotic Mu ¨ller cell morphology (H).
Overlay image of control retinas reveals a close neighbouring of fibronectin and vimentin at the ILM and an overlap of osteopontin and vimentin
especially in Mu ¨ller cell endfeet (I). The disintegrated fibronectin expression is no longer adjacent to Mu ¨ller cell endfeet membranes and no co-
localization of osteopontin and vimentin is detectable in uveitic retina (J). Nuclei are stained with 49,6-diamidino-2-phenylindole (DAPI; blue). ILM,
inner limiting membrane; GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear
layer; OLM, outer limiting membrane.
doi:10.1371/journal.pone.0027674.g002
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a ligand to various intergrin receptors and thus mediates adhesion
and interaction of cells with the ECM [32]. The expression of
fibronectin within the retina was investigated in several studies and
inconsistent results were presented. While some immunohistochem-
ical studies on retinal tissue of human eyes failed to detect
fibronectin [33,34], studies in rat and human retinas demonstrated
positive fibronectin immunoreactivity at the ILM [35,36]. The ILM
is the vitreo-retinal border that represents the connection between
theretina and the vitreous body and was shown tobe builtbyretinal
Mu ¨ller cells that abut this basement membrane with their endfeet
[37,38]. In the present study immunohistochemical stainings of
cultured equine Mu ¨ller cells and eqMC-7 cells confirmed the ability
of Mu ¨ller cells to express fibronectin (Fig. 3A). It was reported that
fibronectin is implicated in adhesion of cultured rat Mu ¨ller cells
[19]. Therefore, our results indicate that fibronectin might be
produced by Mu ¨ller cells to anchor their endfeet membranes to the
ILM and thus contribute to the attachment of the retina to the
vitreous body. Mu ¨ller cells exhibit a special morphology spanning
the entire retinal thickness from the ILM to the OLM that is
essential for many of their functions [39]. Recently, a novel function
of Mu ¨ller cells was described that is facilitated by their special funnel
shape morphology. Mu ¨ller cell endfeet that cover the entire inner
retinal surface, enable a highly efficient entry of light into the cell to
conduct light through the inverted retina, preventing light
scattering. Thus, depending on their special morphology, Mu ¨ller
cells act as optical fibres [40]. Autoimmune uveitis is associated with
an extensive disintegration of the ILM (Fig. 2B) and a loss of the
characteristic Mu ¨ller cell morphology including detachment from
the ILM (Fig. 2H). This detachment could result from the changed
expression pattern of fibronectin in uveitic retinas compared to
healthy controls (Fig. 2C and 2D), since fibronectin was shown to
mediate Mu ¨ller cell adhesion. The even expression of fibronectin
along the ILM and therefore the connection to Mu ¨ller cell endfeet is
demolished in uveitis. This might also affect the entry of light into
the cell, representing a link to a reduced or even a loss of light
conductance and thus vision, which has been reported to be a
consequence of uveitis [41].
Another very important function of Mu ¨ller cells within the
retina is neuroprotection that is performed by the release of
neurotrophic factors as well as by providing various functions that
support neurons in nutrition and metabolism [42]. Recently, we
demonstrated that osteopontin expression in mouse retinal sections
is co-localized to Mu ¨ller cells and osteopontin is also secreted from
cultured mouse Mu ¨ller cells. Furthermore, a positive survival effect
of osteopontin on cultured porcine photoreceptors and reduced
apoptosis in organotypic cultures of retinas derived from rd1 mice,
which carry a mutation in the photoreceptor-specific PDE6b gene,
demonstrated that osteopontin acts neuroprotective [22]. In order
to further evaluate the role of osteopontin in another retinal
disorder, we chose to investigate osteopontin in vitreous and retina
of autoimmune uveitis affected equine eyes. A study in eyes from
humans affected with primary open-angle glaucoma reported a
reduced osteopontin level in vitreous when compared to controls
[43]. However, vitreous of patients with diabetic retinopathy
showed increased osteopontin levels [44]. In the present study, we
showed a significant downregulation of osteopontin in uveitic
vitreous compared to controls (Fig. 1B and 1C). A double band at
Figure 3. Immunocytochemical staining of cultured equine Mu ¨ller cells. Representative image for eqMC-7 cells and primary cultured equine
Mu ¨ller cells stained for fibronectin (magenta), osteopontin (red) and vimentin (green). Fibronectin shows positive immunoreactivity in a spotted
pattern predominantly in the nucleus and the surrounding area (A). Osteopontin is expressed in a thread-like distribution (B). Immunoreactivity for
the intermediate filament vimentin displays an elongated, thread-like expression pattern throughout the entire cell (C). Overlay image reveals partly
co-localisation of fibronectin and osteopontin in the nucleus surrounding area and co-localisation between osteopontin and vimentin stainings
within the equine Mu ¨ller cell (D). Nuclei are stained with DAPI (blue).
doi:10.1371/journal.pone.0027674.g003
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molecular weight of 72 kDa (Fig. 1C) were detected. This is in
agreement with other studies and represents highly variable
posttranslational modifications of osteopontin [43,45,46]. In
healthy equine retinas, osteopontin showed a characteristic Mu ¨ller
cell expression (Fig. 2E and 2I) that was verified in cultured equine
Mu ¨ller cells (Fig. 3B). This finding confirms our previous result in
mouse retinas [22]. In contrast, several studies in mouse, rat and
human retinas demonstrated an immunoreactivity of osteopontin
in retinal ganglion cells, but no expression in Mu ¨ller cells was
described [27,47,48]. Here, we additionally found a positive
osteopontin reaction in the area where photoreceptor outer
segments and microvilli of the RPE intertwine (Fig. 2E). No
reports about the expression of osteopontin in photoreceptors are
available at present whereas expression of osteopontin in the
retinal pigment epithelial cell line ARPE-19 was shown by flow
cytometry [49]. Additionally, the expression of osteopontin mRNA
was detected in cultured bovine RPE cells [50]. Therefore, the
positive immunoreactivity found here, could display microvilli of
the RPE merging into photoreceptor outer segments.
In the present study, a loss of osteopontin expression in Mu ¨ller
cells of retinas from horses with autoimmune uveitis was evident
(Fig. 2F and 2J). Mu ¨ller cells undergo gliotic alteration in
autoimmune uveitis that is associated with changed expression
levels of a set of proteins [20,28]. Gliosis represents a cellular
attempt to protect the tissue from further damage. However,
neuroprotective effects of gliosis oppose its detrimental conse-
quences [51]. Therefore, the expression of osteopontin in Mu ¨ller
cells might represent a neuroprotective attempt that gets lost in
autoimmune uveitis and thus is associated with severe neuronal
damage. Besides our recent report demonstrating the neuropro-
tective effect of osteopontin [22], several other studies revealed a
neuroprotective potential of osteopontin. Reduced cell death was
shown in cortical neuron cultures deprived of glucose and oxygen
and incubated with osteopontin and intracerebral administration
of osteopontin caused a reduction of infarct size in a murine stroke
model [21]. Osteopontin-deficient mice exhibited increased
thalamic neurodegeneration following induction of cortical stroke
[52]. Furthermore, apoptosis in a rat model of hypoxia-ischemia
neonatal brain injury was reduced by osteopontin application [53].
However, studies in IRBP induced EAU in wild-type and
osteopontin-deficient mice demonstrated increased osteopontin
immunoreactivity in wild-type mice and attenuated disease in
osteopontin-deficient mice, assuming a proinflammatory effect of
osteopontin [23,27]. Blockade of osteopontin with small interfering
RNA confirmed the reduced clinical and histopathological scores
in an EAU mouse model compared to controls [24]. The
significant downregulation of osteopontin in vitreous and retinal
Mu ¨ller cells in the spontaneous animal model of autoimmune
uveitis studied here, however, indicates a reduced neuroprotection
potential of Mu ¨ller cells, thus reinforcing the neuroprotective
potential of osteopontin.
In uveitic equine retinas an expression of both, osteopontin and
fibronectin was additionally detected in a rough line aside from the
mostly disintegrated outer limiting membrane (Fig. 2D, 2F, 2J).
Since photoreceptor outer segments degenerate in autoimmune
uveitis, this finding raises the question whether the osteopontin
and fibronectin positive structures belong to retinal tissue or to the
adjacent retinal pigment epithelium. Two studies demonstrated
the ability of cultured RPE cells to express osteopontin [49,50],
however, reports about RPE derived osteopontin in retinal
disorders are currently not available. Although we didn’t detect
fibronectin in healthy RPE, other studies showed that fibronectin
is expressed by RPE cells and promotes the adhesion of RPE to the
ECM [54,55]. Furthermore, an increased expression and secretion
of fibronectin by RPE cells was demonstrated in presence of
human serum [56]. Vascular leakage is a characteristic incident
that occurs with autoimmune uveitis-related breakdown of the
blood-retinal barrier [28]. Therefore, additional investigations on
the expression of osteopontin and fibronectin within the retinal
pigment epithelium in association with autoimmune uveitis are
needed to further assess their role in disease pathogenesis.
Investigations of molecular mechanisms in autoimmune uveitis
are mainly focused on cell-associated proteins, whereas the
knowledge about ECM protein expression in disease pathogenesis
is limited. We aimed to determine the role of ECM in autoimmune
uveitis-related tissues by investigating expression profiles of
relevant ECM proteins. The results indicate severe ECM re-
modeling in autoimmune uveitis highlighted by reduced neuro-
protection mediated by Mu ¨ller cell-derived osteopontin and a loss
of Mu ¨ller cell adhesion through fibronectin. Thus the investigation
of ECM proteins is particularly worthwhile to gain further insight
into the molecular pathomechanisms occurring in autoimmune
uveitis affected tissues. The impact of ECM re-modeling and its
consequences for the surrounding tissue in autoimmune uveitis
merits further investigation.
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